Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer

Chapman, BV and Wald, AI and Akhtar, P and Munko, AC and Xu, J and Gibson, SP and Grandis, JR and Ferris, RL and Khan, SA (2015) MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer, 15 (1).

Published Version
Available under License : See the attached license file.

Download (2MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Background: Squamous cell carcinoma of the head and neck (SCCHN) remains a prevalent and devastating disease. Recently, there has been an increase in SCCHN cases that are associated with high-risk human papillomavirus (HPV) infection. The clinical characteristics of HPV-positive and HPV-negative SCCHN are known to be different but their molecular features are only recently beginning to emerge. MicroRNAs (miRNAs, miRs) are small, non-coding RNAs that are likely to play significant roles in cancer initiation and progression where they may act as oncogenes or tumor suppressors. Previous studies in our laboratory showed that miR-363 is overexpressed in HPV-positive compared to HPV-negative SCCHN cell lines, and the HPV type 16-E6 oncoprotein upregulates miR-363 in SCCHN cell lines. However, the functional role of miR-363 in SCCHN in the context of HPV infection remains to be elucidated. Methods: We analyzed miR-363 levels in SCCHN tumors with known HPV-status from The Cancer Genome Atlas (TCGA) and an independent cohort from our institution. Cell migration studies were conducted following the overexpression of miR-363 in HPV-negative cell lines. Bioinformatic tools and a luciferase reporter assay were utilized to confirm that miR-363 targets the 3'-UTR of myosin 1B (MYO1B). MYO1B mRNA and protein expression levels were evaluated following miR-363 overexpression in HPV-negative SCCHN cell lines. Small interfering RNA (siRNA) knockdown of MYO1B was performed to assess the phenotypic implication of reduced MYO1B expression in SCCHN cell lines. Results: MiR-363 was found to be overexpressed in HPV-16-positive compared to the HPV-negative SCCHN tumors. Luciferase reporter assays performed in HPV-negative JHU028 cells confirmed that miR-363 targets one of its two potential binding sites in the 3'UTR of MYO1B. MYO1B mRNA and protein levels were reduced upon miR-363 overexpression in four HPV-negative SCCHN cell lines. Increased miR-363 expression or siRNA knockdown of MYO1B expression reduced Transwell migration of SCCHN cell lines, indicating that the miR-363-induced migration attenuation of SCCHN cells may act through MYO1B downregulation. Conclusions: These findings demonstrate that the overexpression of miR-363 reduces cellular migration in head and neck cancer and reveal the biological relationship between miR-363, myosin 1b, and HPV-positive SCCHN.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Chapman, BV
Wald, AI
Akhtar, Ppaa13@pitt.eduPAA13
Munko, AC
Xu, J
Gibson, SP
Grandis, JRjgrandis@pitt.eduJGRANDIS
Ferris, RL
Khan, SAkhan@pitt.eduKHAN
Centers: Other Centers, Institutes, Offices, or Units > Pittsburgh Cancer Institute
Date: 6 November 2015
Date Type: Publication
Journal or Publication Title: BMC Cancer
Volume: 15
Number: 1
DOI or Unique Handle: 10.1186/s12885-015-1888-3
Schools and Programs: School of Medicine > Immunology
School of Medicine > Microbiology and Molecular Genetics
School of Medicine > Otolaryngology
School of Medicine > Pharmacology and Chemical Biology
Refereed: Yes
Date Deposited: 18 Aug 2016 19:44
Last Modified: 30 Mar 2021 13:56


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item